Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $28.4000 (-19.46%) ($27.8500 - $34.9000) on Thu. Jan. 3, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.08% (three month average) | RSI | 22 | Latest Price | $28.4000(-19.46%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA declines -3.4% a day on average for past five trading days. | Weekly Trend | ATRA declines -9.8% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(58%) ARKG(50%) IBB(50%) IWO(49%) ARKK(48%) | Factors Impacting ATRA price | ATRA will decline at least -2.54% in a week (0% probabilities). VXX(-14%) TLT(-14%) VIXM(-12%) UUP(-12%) UNG(-5%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.54% (StdDev 5.08%) | Hourly BBV | 0 () | Intraday Trend | -18.6% | | | |
|
1 - 5 Day Possible Target | $12.13(-57.29%) | Resistance Level | $37.09 | 5 Day Moving Average | $33.44(-15.07%) | 10 Day Moving Average | $33.45(-15.1%) | 20 Day Moving Average | $37.09(-23.43%) | To recent high | -33.9% | To recent low | 0% | Market Cap | $2.11b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |